HomeABUS • NASDAQ
add
Arbutus Biopharma Corp
$4.72
Makalipas ang Oras ng Trabaho:(1.02%)-0.048
$4.67
Sarado: Dis 29, 4:30:00 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$4.78
Sakop ng araw
$4.66 - $4.81
Sakop ng taon
$2.71 - $5.10
Market cap
907.77M USD
Average na Volume
1.24M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 529.00K | -60.49% |
Gastos sa pagpapatakbo | 3.04M | -32.91% |
Net na kita | -7.74M | 60.73% |
Net profit margin | -1.46K | 0.61% |
Kita sa bawat share | -0.06 | 59.57% |
EBITDA | -8.28M | 51.67% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 93.70M | -26.68% |
Kabuuang asset | 97.71M | -30.43% |
Kabuuang sagutin | 20.31M | -39.46% |
Kabuuang equity | 77.40M | — |
Natitirang share | 192.32M | — |
Presyo para makapag-book | 11.95 | — |
Return on assets | -20.63% | — |
Return on capital | -24.39% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -7.74M | 60.73% |
Cash mula sa mga operasyon | -5.82M | 71.95% |
Cash mula sa pag-invest | -10.02M | 16.41% |
Cash mula sa financing | 844.00K | -52.45% |
Net change in cash | -15.00M | 51.51% |
Malayang cash flow | -2.55M | 76.57% |
Tungkol
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Itinatag
2007
Headquarters
Website
Mga Empleyado
44
